PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.\', \'Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK. Electronic address: shaun.pennington@lstmed.ac.uk.\', \'Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK; Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.\', \'Department of Chemistry, University of Liverpool, Liverpool, UK.\', \'Department of Pharmacology and Therapeutics, Centre of Excellence in Long-acting Therapeutics, University of Liverpool, Liverpool, UK.\', \'Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK. Electronic address: giancarlo.biagini@lstmed.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0924-8579(22)00030-910.1016/j.ijantimicag.2022.106542
?:hasPublicationType
?:journal
  • International journal of antimicrobial agents
is ?:pmid of
?:pmid
?:pmid
  • 35093538
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 107
?:title
  • Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all